TLRY Archives - BioPharmaJournal

Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...

Ward Sport - June 30, 2022 0

Top Cannabis Ideas as Pot Stocks Become Deep Value Investment Theme...

Matt Wade - May 19, 2022 0

Top Opportunities in the Oversold Cannabis Stock Space (ACB, SGMD, TCNNF,...

Ward Sport - May 4, 2022 0

Which Cannabis Stocks Will Benefit from the Coming Tailwind (SNDL, CBGL,...

Gavins Felicity - April 21, 2022 0

Fresh Opportunities in Focus as Pot Stocks Launch on Legalization Potential...

Ash K - March 31, 2022 0

Why Cannabis Stocks Stand Out as Speculative Opportunity for New Growth...

Matt Wade - March 16, 2022 0

The Legislative Tailwind is Back for Cannabis Stocks (TCNNF, CBGL. GRWG,...

Gavins Felicity - March 2, 2022 0

Is the next Green Wave underway in Pot Stocks? (TLRY, ECGI,...

Gavins Felicity - February 16, 2022 0

CLS Holdings USA (CLSH) anticipates YOY revenue growth to accelerate while...

Ash K - February 8, 2022 0

Has Tilray Inc (NASDAQ:TLRY) Hit Bottom?

Gavins Felicity - January 12, 2022 0

12 3 Page 1 of 3

Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...

Kate Hudson - August 5, 2022 0

Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...

IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...

August 4, 2022

Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...

August 3, 2022

Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study...

August 2, 2022

Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A....

August 1, 2022

Tag: TLRY

Recent Post